Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules

被引:33
作者
Eszlinger, M
Krohn, K
Frenzel, R
Kropf, S
Tönjes, A
Paschke, R
机构
[1] Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany
[2] Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany
[3] Univ Magdeburg, Inst Biometr & Med Informat, D-39120 Magdeburg, Germany
关键词
thyroid; TSH receptor; signal transduction; transforming growth factor beta 1; sialyltransferase; 1;
D O I
10.1038/sj.onc.1207186
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular eventsthat lead to the development of autonomously functioning thyroid nodules (AFTNs) are somatic mutations of the thyrotropin receptor (TSHR) in approximately 60% of the nodules and less frequently, somatic mutations in the G(s)alpha protein. However, AFTNs without known mutations indicate that other causes remain to be identified. Moreover, the impact of constitutively activating TSHR mutations on the signal transduction network of the thyroid epithelial cell is unknown. We therefore investigated gene expression in 15 AFTNs and their surrounding tissue using Affymetrix GeneChips. Most prominently, data analysis revealed a changed pattern of gene expression in the TGF-beta signaling cascade and 25 differentially regulated genes in AFTNs, including thyroid peroxidase, type I iodothyronine deiodinase and sialyltransferase ( SIAT) 1. Strikingly coexpression of SIAT 1 and TSHR in COS-7 cells increased TSH binding and cell surface expression of the TSHR. Moreover, differences in gene expression patterns for AFTNs with and without TSHR mutations indicate specific alterations of signal transduction in AFTNs without TSHR mutations. These results suggest that AFTNs with TSHR mutations harbor further mechanisms of forward stimulation. Furthermore, they give important leads to elucidate the molecular etiology of AFTNs without TSHR mutations.
引用
收藏
页码:795 / 804
页数:10
相关论文
共 42 条
[1]  
[Anonymous], 1993, Resampling-based multiple testing: Examples and methods for P-value adjustment
[2]   Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features [J].
Arturi, F ;
Capula, C ;
Chiefari, E ;
Filetti, S ;
Russo, D .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (03) :234-236
[3]   A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling [J].
Biebermann, H ;
Schöneberg, T ;
Schulz, A ;
Krause, G ;
Grüters, A ;
Schultz, G ;
Gudermann, T .
FASEB JOURNAL, 1998, 12 (14) :1461-1471
[4]  
COLLETTA G, 1989, CANCER RES, V49, P3457
[5]   Metallothionein: The multipurpose protein [J].
Coyle, P ;
Philcox, JC ;
Carey, LC ;
Rofe, AM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (04) :627-647
[6]   GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways [J].
Dahlquist, KD ;
Salomonis, N ;
Vranizan, K ;
Lawlor, SC ;
Conklin, BR .
NATURE GENETICS, 2002, 31 (01) :19-20
[7]   Transforming growth factor β1 selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27kip1 [J].
Depoortere, F ;
Pirson, I ;
Bartek, J ;
Dumont, JE ;
Roger, PP .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (03) :1061-1076
[8]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[9]   Complementary DNA expression array analysis suggests a lower expression of signal transduction proteins and receptors in cold and hot thyroid nodules [J].
Eszlinger, M ;
Krohn, K ;
Paschke, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4834-4842
[10]   Growth factor expression in cold and hot thyroid nodules [J].
Eszlinger, M ;
Krohn, K ;
Kratzsch, J ;
Voigt, C ;
Paschke, R .
THYROID, 2001, 11 (02) :125-135